Welcome to our dedicated page for Envoy Medical news (Ticker: COCH), a resource for investors and traders seeking the latest updates and insights on Envoy Medical stock.
Envoy Medical Inc. (NASDAQ: COCH) is a leader in fully implanted hearing solutions, pioneering devices that redefine hearing restoration. This page provides authorized news updates and official press releases directly from the company, offering stakeholders a centralized resource for tracking critical developments.
Investors and healthcare professionals will find timely updates on FDA milestones, clinical trial progress for the Acclaim® Cochlear Implant, and strategic partnerships shaping the future of hearing health. Our curated feed includes product launch announcements, regulatory filings, and analyses of industry trends affecting sensorineural hearing loss treatment.
Key focus areas include advancements in implantable hearing technology, legislative updates impacting device accessibility, and peer-reviewed clinical data. Bookmark this page to stay informed about Envoy Medical's innovations in cochlear implants and middle ear prosthetics, backed by 30+ patents and Breakthrough Device Designations.
Envoy Medical (Nasdaq: COCH) reported its Q1 2024 results, highlighting progress in its fully implanted cochlear implant development. All three participants in the Early Feasibility Study (EFS) at Mayo Clinic completed their 12-month follow-ups and continue using their devices daily. The company plans to file an Investigational Device Exemption (IDE) application for a pivotal clinical trial later in 2024 but has converted the current IDE application to a pre-submission for additional data collection and discussions with the FDA.
Financially, Envoy Medical reported revenue of $59K, down from $78K in Q1 2023. R&D expenses increased by $0.4M due to higher personnel costs. Sales and marketing expenses decreased by $46K, while general and administrative expenses rose by $0.7M. The company secured a $10M lending facility from investor Glen Taylor, with $5M drawn initially. Cash and cash equivalents stood at $4.9M as of March 31, 2024.
FAQ
What is the current stock price of Envoy Medical (COCH)?
What is the market cap of Envoy Medical (COCH)?
